Percutaneous Coronary Intervention (PCI) Clinical Trials

Clinical trials related to Percutaneous Coronary Intervention (PCI) Procedure

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized multicenter trial compares coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) in 358 patients with ischemic left ventricular dysfunction and multivessel coronary disease. The study evaluates differences in survival, major cardiovascular events, and quality of life over 4 years, and contributes to the international STICH 3.0 collaboration assessing long-term outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥ 18 years

• LVEF≤ 40%

• Angina pectoris, CCS≥2 and/or hospitalization for ACS or heart failure within 1 year prior to randomization

• Multivessel CAD (2-3 vessel-disease with coronary lesions \>70% and involvement of proximal LAD, and/or LM stenosis of \>50%). Target vessels are determined by the local Heart Time

• Clinical and angiographical characteristics suitable for isolated coronary revascularization both by CABG or PCI according to the judgment of the local Heart Team

• Written informed consent

Locations
Other Locations
Netherlands
University Medical Center Groningen
RECRUITING
Groningen
Contact Information
Primary
Erik Lipsic, Dr
e.lipsic@umcg.nl
+31 50 3612355
Backup
Ruben R. De With, Dr
r.r.de.with@umcg.nl
+31 50 3612355
Time Frame
Start Date: 2026-05
Estimated Completion Date: 2034-05
Participants
Target number of participants: 358
Treatments
Experimental: CABG (surgery)
Patients randomized to CABG will receive CABG - aiming for full revascularization
Other: PCI (percutaneous)
Patients randomized to PCI will receive PCI - aiming for full revascularization
Sponsors
Collaborators: Dutch Heart Foundation
Leads: University Medical Center Groningen

This content was sourced from clinicaltrials.gov